A woman in an undisclosed location successfully delivered a baby vaginally after a previous Cesarean section, despite experiencing significant postpartum hemorrhage, thanks to a device called the JADA® System. The hemorrhage occurred following the vaginal birth after Cesarean (VBAC) delivery, requiring immediate intervention to control the bleeding.
The JADA® System, manufactured by Organon and Laborie, is designed to control abnormal postpartum uterine bleeding or hemorrhage. It utilizes a low-level vacuum to induce physiological contraction of the uterus, effectively addressing the bleeding. According to information released by Organon, the system can achieve visible control of bleeding within minutes, with a median control time of three minutes in clinical trials.
The device is intended for use when conservative management approaches are deemed appropriate. It works by applying a vacuum pressure of 80 mm Hg +/- 10 mm Hg, not exceeding 90 mm Hg. This low-level vacuum stimulates the uterus to contract, thereby controlling the hemorrhage. The JADA® System is currently available in over 2,000 hospitals across the United States and is often found on hemorrhage carts for rapid deployment.
Clinical studies, including the RUBY and PEARLE trials, support the effectiveness and ease of use of the JADA® System. Investigators in nearly every case rated the device as easy to use. The system is indicated for the control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted, as outlined in a quick reference guide released by Organon.
The specific details of the case, including the patient’s age, medical history, and the volume of blood loss, have not been publicly released. Organon has not responded to requests for further information regarding the case or the ongoing monitoring of patients treated with the JADA® System.
